Treace Fixed Asset Turnover from 2010 to 2024

TMCI Stock  USD 8.52  0.04  0.47%   
Treace Medical's Fixed Asset Turnover is decreasing with slightly volatile movements from year to year. Fixed Asset Turnover is predicted to flatten to 5.63. For the period between 2010 and 2024, Treace Medical, Fixed Asset Turnover quarterly trend regression had mean deviation of  10.07 and range of 63.6303. View All Fundamentals
 
Fixed Asset Turnover  
First Reported
2010-12-31
Previous Quarter
5.92858501
Current Value
5.63
Quarterly Volatility
15.80626988
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Treace Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Treace Medical's main balance sheet or income statement drivers, such as Net Interest Income of 202.7 K, Interest Income of 5.6 M or Depreciation And Amortization of 2.8 M, as well as many indicators such as Price To Sales Ratio of 3.94, Dividend Yield of 0.0 or PTB Ratio of 5.34. Treace financial statements analysis is a perfect complement when working with Treace Medical Valuation or Volatility modules.
  
Check out the analysis of Treace Medical Correlation against competitors.

Latest Treace Medical's Fixed Asset Turnover Growth Pattern

Below is the plot of the Fixed Asset Turnover of Treace Medical Concepts over the last few years. It is Treace Medical's Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Treace Medical's overall financial position and show how it may be relating to other accounts over time.
Fixed Asset Turnover10 Years Trend
Slightly volatile
   Fixed Asset Turnover   
       Timeline  

Treace Fixed Asset Turnover Regression Statistics

Arithmetic Mean30.89
Geometric Mean25.10
Coefficient Of Variation51.16
Mean Deviation10.07
Median34.39
Standard Deviation15.81
Sample Variance249.84
Range63.6303
R-Value(0.42)
Mean Square Error221.31
R-Squared0.18
Significance0.12
Slope(1.49)
Total Sum of Squares3,498

Treace Fixed Asset Turnover History

2024 5.63
2023 5.93
2022 5.57
2021 33.14
2020 69.2

About Treace Medical Financial Statements

Investors use fundamental indicators, such as Treace Medical's Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Although Treace Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Fixed Asset Turnover 5.93  5.63 

Currently Active Assets on Macroaxis

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:
Check out the analysis of Treace Medical Correlation against competitors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
3.274
Quarterly Revenue Growth
0.106
Return On Assets
(0.17)
Return On Equity
(0.51)
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.